Literature DB >> 33441784

Insulin resistance is associated with poor functional outcome after acute ischemic stroke in non-diabetic patients.

Yoonkyung Chang1, Chi Kyung Kim2, Min-Kyung Kim2, Woo-Keun Seo3, Kyungmi Oh4.   

Abstract

Insulin resistance is associated with the occurrence of stroke and atherosclerotic disease. However, the relationship between insulin resistance and the prognosis of acute ischemic stroke in non-diabetic patients is unclear. We hypothesized that insulin resistance might affect short-term functional recovery after acute ischemic stroke in non-diabetic patients. Between May 2014 and December 2016, 1377 consecutive patients with acute ischemic stroke were enrolled from a prospectively maintained stroke registry. After excluding patients with transient ischemic attacks (TIA), pre-stroke disabilities, diabetes mellitus, and patients with incomplete evaluations, 517 patients were included in the study. The homeostasis model assessment of insulin resistance (HOMA-IR) score was used to evaluate the degree of insulin resistance. The patients with the highest quartile of log HOMA-IR index scores were younger and had higher fasting blood glucose, total cholesterol, triglycerides, low-density lipoprotein, and HbA1c levels. Multivariable logistic regression analysis revealed that log HOMA-IR scores were independently associated with poor prognosis after adjusting for age and sex and p < 0.1 in univariable analysis. Insulin resistance was associated with the poor functional outcome of non-diabetic stroke patients. This evidence supports treating insulin resistance in acute ischemic stroke patients with blood glucose levels within the normal range.

Entities:  

Year:  2021        PMID: 33441784      PMCID: PMC7806587          DOI: 10.1038/s41598-020-80315-z

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  35 in total

1.  Hyperglycemia in acute stroke.

Authors:  Perttu J Lindsberg; Risto O Roine
Journal:  Stroke       Date:  2004-02       Impact factor: 7.914

Review 2.  Insulin in the brain.

Authors:  D G Baskin; D P Figlewicz; S C Woods; D Porte; D M Dorsa
Journal:  Annu Rev Physiol       Date:  1987       Impact factor: 19.318

3.  SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.

Authors:  Thomas A Zelniker; Stephen D Wiviott; Itamar Raz; Kyungah Im; Erica L Goodrich; Marc P Bonaca; Ofri Mosenzon; Eri T Kato; Avivit Cahn; Remo H M Furtado; Deepak L Bhatt; Lawrence A Leiter; Darren K McGuire; John P H Wilding; Marc S Sabatine
Journal:  Lancet       Date:  2018-11-10       Impact factor: 79.321

4.  Endothelium-specific insulin resistance leads to accelerated atherosclerosis in areas with disturbed flow patterns: a role for reactive oxygen species.

Authors:  Matthew C Gage; Nadira Y Yuldasheva; Hema Viswambharan; Piruthivi Sukumar; Richard M Cubbon; Stacey Galloway; Helen Imrie; Anna Skromna; Jessica Smith; Christopher L Jackson; Mark T Kearney; Stephen B Wheatcroft
Journal:  Atherosclerosis       Date:  2013-06-29       Impact factor: 5.162

5.  Dysregulation of insulin receptor substrate 2 in beta cells and brain causes obesity and diabetes.

Authors:  Xueying Lin; Akiko Taguchi; Sunmin Park; Jake A Kushner; Fan Li; Yedan Li; Morris F White
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

Review 6.  Insulin action and insulin resistance in vascular endothelium.

Authors:  Ranganath Muniyappa; Michael J Quon
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2007-07       Impact factor: 4.294

7.  Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

Authors:  H P Adams; B H Bendixen; L J Kappelle; J Biller; B B Love; D L Gordon; E E Marsh
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

8.  Higher Insulin Resistance Level is Associated with Worse Clinical Response in Acute Ischemic Stroke Patients Treated with Intravenous Thrombolysis.

Authors:  Demet Funda Bas; Atilla Ozcan Ozdemir; Ertuğrul Colak; Nur Kebapci
Journal:  Transl Stroke Res       Date:  2016-01-30       Impact factor: 6.829

Review 9.  Risk of dementia in diabetes mellitus: a systematic review.

Authors:  Geert Jan Biessels; Salka Staekenborg; Eric Brunner; Carol Brayne; Philip Scheltens
Journal:  Lancet Neurol       Date:  2006-01       Impact factor: 44.182

Review 10.  Complex mechanisms linking neurocognitive dysfunction to insulin resistance and other metabolic dysfunction.

Authors:  Luke E Stoeckel; Zoe Arvanitakis; Sam Gandy; Dana Small; C Ronald Kahn; Alvaro Pascual-Leone; Aaron Pawlyk; Robert Sherwin; Philip Smith
Journal:  F1000Res       Date:  2016-03-15
View more
  5 in total

Review 1.  Calorie restriction or dietary restriction: how far they can protect the brain against neurodegenerative diseases?

Authors:  Tayana Silva de Carvalho
Journal:  Neural Regen Res       Date:  2022-08       Impact factor: 5.135

2.  Short-Term Prognostic Predictive Evaluation in Female Patients With Ischemic Stroke: A Retrospective Cross-Sectional Study.

Authors:  Fettah Eren; Cihat Ozguncu; Serefnur Ozturk
Journal:  Front Neurol       Date:  2022-03-24       Impact factor: 4.003

Review 3.  Recent Advances in the Treatment of Insulin Resistance Targeting Molecular and Metabolic Pathways: Fighting a Losing Battle?

Authors:  Marta Wolosowicz; Slawomir Prokopiuk; Tomasz W Kaminski
Journal:  Medicina (Kaunas)       Date:  2022-03-25       Impact factor: 2.948

Review 4.  Molecular mechanisms underlying some major common risk factors of stroke.

Authors:  Reem Alkahtani
Journal:  Heliyon       Date:  2022-08-18

5.  Association of triglyceride-glucose index with clinical outcomes in patients with acute ischemic stroke receiving intravenous thrombolysis.

Authors:  Emma M S Toh; Amanda Y L Lim; Chua Ming; Leonard L L Yeo; Ching-Hui Sia; Bryce W Q Tan; Aloysius S T Leow; Jamie S Y Ho; Bernard P L Chan; Vijay Kumar Sharma; Benjamin Y Q Tan
Journal:  Sci Rep       Date:  2022-01-31       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.